<DOC>
	<DOCNO>NCT02411877</DOCNO>
	<brief_summary>The purpose study determine whether reduce patient 's body temperature ( mild hypothermia 33 degree Centigrade ) significantly reduce risk brain injury ( notably reperfusion injury hemorrhagic conversion ) patient suffer significant interruption blood flow area brain ( occlusion large proximal cerebral artery ) undergone successful removal interruption ( revascularization ) .This achieved compare patient undergone hypothermia .</brief_summary>
	<brief_title>REperfusion With Cooling CerebraL Acute IscheMia II</brief_title>
	<detailed_description>This study design examine safety proof concept therapeutic hypothermia prior conventional revascularization subject experience acute ischemic stroke compare result subject remain normal body temperature ( normothermic ) proceed directly reperfusion via conventional reperfusion intervention . The investigational plan also examine follow outcomes 85 subject randomize either hypothermia normothermia : - Regulation biomarkers indicative ischemia-reperfusion injury - Changes blood brain injury use Hyperintense Acute Reperfusion Marker ( HARM ) protocol MRI surrogate image biomarker - Incidence hemorrhagic conversion post reperfusion - Neurologic function 90 day post acute ischemic stroke . The result study used power definitive phase III clinical trial evaluate combination hypothermia revascularization versus reperfusion alone .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Hypothermia</mesh_term>
	<criteria>Male female subject ethnicity age &gt; /=18 &lt; /= 79 year ; Symptom onset &lt; /=8 hour ; Symptoms consistent ischemic stroke large vessel occlusion ( Middle Cerebral Artery ( MCA ) , Internal Carotid Artery ( ICA ) terminus ) determine CT image brain ; Alberta Stroke Program Early CT Score ( ASPECTS ) 510 noncontrast CT brain ; Ability undergo endovascular reperfusion therapy ; No contraindication general anesthesia , conscious sedation , allergies component associate anticipated diagnostic treatment procedure treat ; A pretreatment modify Rankin Scale ( mRS ) 0 1 ; Baseline CT scan show hemorrhage ; National Institutes Health Stroke Scale ( NIHSS ) 1429 ; Subject either 1 ) fail iv tissue plasminogen activator ( tPA ) therapy 2 ) contradict iv tPA therapy ; Subject capable complying study procedure agree complete require study procedure , study visit associate activity . Subject legally authorize representative must able understand give write informed consent . Females childbearing potential pregnant use adequate contraception ; Bleeding diathesis platelet count &lt; 50,000 International Normalized Ratio ( INR ) &gt; 1.7 active recent ( within 10 30 day ) hemorrhage ; History genetically confirm hypercoagulable syndrome ; Any condition exclude MRI imaging ; History dementia , currently Aricept Namenda , Alzheimer'slike symptom ; End stage renal disease hemodialysis ; History cardiac arrest ; Presence inferior vena cava ( IVC ) filter ; Contrast dye allergy history anaphylaxis , know serious sensitivity contrast agent condition angiography contraindicate ; Known allergy meperidine buspar ; Prior neurologic event would obscure interpretation signal current present neurologic deficit ; Sustained hypertension ( systolic blood pressure ( SBP ) &gt; 185 diastolic blood pressure ( DBP ) &gt; 110 refractory treatment ) ; Baseline CT/MRI head show evidence mass effect midline shift , hemorrhage , intracranial tumor , arterial vasculitis dissection , bilateral stroke ; Presence serious comorbidity would likely impact life expectancy le 6 month limit subject cooperation study compliance ; Concurrent participation investigational clinical study complete followup period plan participation another study within next 3 month ; Any condition personal circumstance , judgment investigator , might interfere collection complete , good quality data completion research study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Acute ischemic stroke</keyword>
	<keyword>Mild hypothermia</keyword>
	<keyword>Stroke</keyword>
	<keyword>Hypothermia</keyword>
	<keyword>Cerebral infarction</keyword>
	<keyword>Ischemia</keyword>
	<keyword>Cerebrovascular disorder</keyword>
	<keyword>Brain disease</keyword>
	<keyword>Central nervous system disease</keyword>
	<keyword>Nervous system disease</keyword>
	<keyword>Vascular disease</keyword>
	<keyword>Cardiovascular disease</keyword>
	<keyword>Brain infarction</keyword>
	<keyword>Brain ischemia</keyword>
	<keyword>Pathologic process</keyword>
	<keyword>Body temperature change</keyword>
	<keyword>Signs symptom</keyword>
</DOC>